Guangdong VTR Bio-Tech Co Ltd - Class A

SZSE:300381 (China)   Class A
Â¥ 6.28 (-4.85%) Jun 6
136.52
P/B:
1.17
Market Cap:
Â¥ 3.08B ($ 424.82M)
Enterprise V:
Â¥ 2.25B ($ 310.61M)
Volume:
17.49M
Avg Vol (2M):
29.95M
Volume:
17.49M
Avg Vol (2M):
29.95M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Guangdong VTR Bio-Tech Co Ltd ( SZSE:300381 ) from 2014 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Guangdong VTR Bio-Tech stock (SZSE:300381) PE ratio as of Jun 06 2024 is 136.52. More Details

Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) PE Ratio (TTM) Chart

To

Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) PE Ratio (TTM) Historical Data

Total 1199
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Guangdong VTR Bio-Tech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 136.5 2024-03-28 119.8
2024-06-05 143.5 2024-03-27 At Loss
2024-06-04 147.6 2024-03-26 At Loss
2024-06-03 150.0 2024-03-25 At Loss
2024-05-31 152.8 2024-03-22 At Loss
2024-05-30 153.0 2024-03-21 At Loss
2024-05-29 154.6 2024-03-20 At Loss
2024-05-28 157.8 2024-03-19 At Loss
2024-05-27 155.4 2024-03-18 At Loss
2024-05-24 160.9 2024-03-15 At Loss
2024-05-23 155.4 2024-03-14 At Loss
2024-05-22 162.0 2024-03-13 At Loss
2024-05-21 165.0 2024-03-12 At Loss
2024-05-20 172.2 2024-03-11 At Loss
2024-05-17 170.0 2024-03-08 At Loss
2024-05-16 170.7 2024-03-07 At Loss
2024-05-15 174.8 2024-03-06 At Loss
2024-05-14 176.1 2024-03-05 At Loss
2024-05-13 187.4 2024-03-04 At Loss
2024-05-10 192.2 2024-03-01 At Loss
2024-05-09 188.9 2024-02-29 At Loss
2024-05-08 189.1 2024-02-28 At Loss
2024-05-07 184.8 2024-02-27 At Loss
2024-05-06 193.5 2024-02-26 At Loss
2024-04-30 163.0 2024-02-23 At Loss
2024-04-29 135.9 2024-02-22 At Loss
2024-04-26 117.6 2024-02-21 At Loss
2024-04-25 107.8 2024-02-20 At Loss
2024-04-24 107.0 2024-02-19 At Loss
2024-04-23 103.9 2024-02-08 At Loss
2024-04-22 100.4 2024-02-07 At Loss
2024-04-19 98.0 2024-02-06 At Loss
2024-04-18 98.9 2024-02-05 At Loss
2024-04-17 102.2 2024-02-02 At Loss
2024-04-16 91.3 2024-02-01 At Loss
2024-04-15 105.0 2024-01-31 At Loss
2024-04-12 113.7 2024-01-30 At Loss
2024-04-11 117.0 2024-01-29 At Loss
2024-04-10 118.9 2024-01-26 At Loss
2024-04-09 122.8 2024-01-25 At Loss
2024-04-08 118.0 2024-01-24 At Loss
2024-04-03 123.7 2024-01-23 At Loss
2024-04-02 125.0 2024-01-22 At Loss
2024-04-01 123.7 2024-01-19 At Loss
2024-03-29 120.4 2024-01-18 At Loss

Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.